Two further cases of tuberculosis in a renal allograft.
- Published in:
- Transplant Infectious Disease, 2000, v. 2, n. 1, p. 44, doi. 10.1034/j.1399-3062.2000.020109.x
- By:
- Publication type:
- Article
Works by Lorimer, I
Results: 8
1
2
Tuberculosis isolated to the renal allograft.
- Published in:
- Transplant Infectious Disease, 1999, v. 1, n. 1, p. 83, doi. 10.1034/j.1399-3062.1999.10109.x
- By:
- Publication type:
- Article
3
P.020 Avelumab in newly diagnosed glioblastoma multiforme-the SEJ study.
- Published in:
- Canadian Journal of Neurological Sciences, 2019, v. 46, p. S18, doi. 10.1017/cjn.2019.120
- By:
- Publication type:
- Article
4
Development of the profession.
- Published in:
- 2009
- By:
- Publication type:
- Letter
5
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 147, doi. 10.1007/s10637-005-5860-y
- By:
- Publication type:
- Article
6
Repression of cancer cell senescence by PKCι.
- Published in:
- Oncogene, 2012, v. 31, n. 31, p. 3584, doi. 10.1038/onc.2011.524
- By:
- Publication type:
- Article
7
Regulation of glioblastoma cell invasion by PKCι and RhoB.
- Published in:
- Oncogene, 2008, v. 27, n. 25, p. 3587, doi. 10.1038/sj.onc.1211027
- By:
- Publication type:
- Article
8
Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling.
- Published in:
- Oncogene, 2006, v. 25, n. 20, p. 2909, doi. 10.1038/sj.onc.1209312
- By:
- Publication type:
- Article